Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Tomassi

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
ACS Medicinal Chemistry Letters|May 22, 2020
From PARP1 to TNKS2 Inhibition: A Structure-Based ApproachStefano Tomassi, Julian Pfahler, Nicola Mautone, et al.
Journal of Medicinal Chemistry|February 5, 2025
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin LigandsBeatrice Stefanie Ludwig, Nils Krautkremer, Stefano Tomassi, et al.
Plos One|June 22, 2022
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactionsBianca Wiedemann, Dominic Kamps, Laura Depta, et al.
Chemmedchem|February 8, 2014
Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cellsAlessia Lenoci, Stefano Tomassi, Mariarosaria Conte, et al.
Biochimie|June 20, 2012
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cellsSergio Valente, Ilaria Lepore, Carmela Dell'Aversana, et al.
Biomaterials|March 23, 2021
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrinsBeatrice Stefanie Ludwig, Stefano Tomassi, Salvatore Di Maro, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of Pyrido[3',2':5,6]thiopyrano[4,3-<i>d</i>]pyrimidine-Based Antiproliferative Multikinase InhibitorsSilvia Salerno, Elisabetta Barresi, Aída Nelly García-Argáez, et al.
Journal of Medicinal Chemistry|March 10, 2018
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer CellsDiego Brancaccio, Donatella Diana, Salvatore Di Maro, et al.
Journal of Medicinal Chemistry|February 21, 2022
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR AgonistsStefano Tomassi, Marilisa Pia Dimmito, Minying Cai, et al.
Angewandte Chemie (International Ed. in English)|April 17, 2018
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective LigandsFrancesco Saverio Di Leva, Stefano Tomassi, Salvatore Di Maro, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|May 22, 2020
From PARP1 to TNKS2 Inhibition: A Structure-Based ApproachStefano Tomassi, Julian Pfahler, Nicola Mautone, et al.
Journal of Medicinal Chemistry|February 5, 2025
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin LigandsBeatrice Stefanie Ludwig, Nils Krautkremer, Stefano Tomassi, et al.
Plos One|June 22, 2022
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactionsBianca Wiedemann, Dominic Kamps, Laura Depta, et al.
Chemmedchem|February 8, 2014
Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cellsAlessia Lenoci, Stefano Tomassi, Mariarosaria Conte, et al.
Biochimie|June 20, 2012
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cellsSergio Valente, Ilaria Lepore, Carmela Dell'Aversana, et al.
Biomaterials|March 23, 2021
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrinsBeatrice Stefanie Ludwig, Stefano Tomassi, Salvatore Di Maro, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of Pyrido[3',2':5,6]thiopyrano[4,3-<i>d</i>]pyrimidine-Based Antiproliferative Multikinase InhibitorsSilvia Salerno, Elisabetta Barresi, Aída Nelly García-Argáez, et al.
Journal of Medicinal Chemistry|March 10, 2018
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer CellsDiego Brancaccio, Donatella Diana, Salvatore Di Maro, et al.
Journal of Medicinal Chemistry|February 21, 2022
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR AgonistsStefano Tomassi, Marilisa Pia Dimmito, Minying Cai, et al.
Angewandte Chemie (International Ed. in English)|April 17, 2018
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective LigandsFrancesco Saverio Di Leva, Stefano Tomassi, Salvatore Di Maro, et al.
Pageof 5